4//SEC Filing
SHARMA PANNA 4
Accession 0001213900-22-045909
CIK 0001763950other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:26 PM ET
Size
5.6 KB
Accession
0001213900-22-045909
Insider Transaction Report
Form 4
SHARMA PANNA
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-08-06+100,000→ 100,000 totalExercise: $5.60Exp: 2032-08-06→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options will vest and first become exercisable in equal monthly increments over a 36-month period commencing September 8, 2022, with the vesting of the options to accelerate in the event the closing price for our common stock is at least $15.00 per share.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001157989
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:26 PM ET
- Size
- 5.6 KB